Clinical Trial Results:
Open-label, multi-center, sequential group, clinical study to determine the safety and efficacy of escalating dosing regimens of intravenous or oral BAL8557 in the prophylaxis of patients undergoing chemotherapy for acute myeloid leukemia
Summary
|
|
EudraCT number |
2005-005294-30 |
Trial protocol |
DE |
Global completion date |
18 May 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Feb 2019
|
First version publication date |
01 Feb 2019
|
Other versions |
|
Summary report(s) |
Clinical Study Report Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.